TABLE OF CONTENTS
1 EXECUTIVE SUMMARY
1.1 OVERVIEW
1.1.1 MARKET SYNOPSIS
2 MARKET INTRODUCTION
2.1 DEFINITION
2.2 SCOPE OF THE STUDY
2.3 RESEARCH OBJECTIVE
2.4 MARKET STRUCTURE
2.5 LIST OF ASSUMPTIONS
3 RESEARCH METHODOLOGY
3.1 OVERVIEW
3.2 DATA MINING
3.3 SECONDARY RESEARCH
3.4 PRIMARY RESEARCH
3.4.1 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS
3.4.2 BREAKDOWN OF PRIMARY RESPONDENTS
3.5 FORECASTING TECHNIQUES
3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION
3.6.1 BOTTOM-UP APPROACH
3.6.2 TOP-DOWN APPROACH
3.7 DATA TRIANGULATION
3.8 VALIDATION
4 MARKET DYNAMICS
4.1 OVERVIEW
4.2 DRIVERS
4.2.1 INCREASING ADOPTION OF AI IN DRUG DISCOVERY
4.2.2 RISING STRATEGIC INITIATIVES FOR AI IN DRUG DISCOVERY
4.2.3 INCREASING NUMBER OF AI-POWERED DRUG DISCOVERY START-UPS
4.3 RESTRAINTS
4.3.1 SHORTAGE OF AI WORKFORCE
4.4 OPPORTUNITIES
4.4.1 EMERGING MARKETS
5 MARKET FACTOR ANALYSIS
5.1 VALUE CHAIN ANALYSIS
5.1.1 R&D
5.1.2 MANUFACTURING
5.1.3 DISTRIBUTION & SALES
5.1.4 POST-SALES MONITORING
5.2 PORTER'S FIVE FORCES MODEL
5.2.1 THREAT OF NEW ENTRANTS
5.2.2 BARGAINING POWER OF SUPPLIERS
5.2.3 THREAT OF SUBSTITUTES
5.2.4 BARGAINING POWER OF BUYERS
5.2.5 INTENSITY OF RIVALRY
5.3 IMPACT OF COVID-19 ON THE GLOBAL AI IN DRUG DISCOVERY
5.3.1 IMPACT ON SUPPLY CHAIN
5.3.2 IMPACT ON SERVICE DEMAND
5.3.3 IMPACT ON MARKET PLAYERS
6 GLOBAL AI IN DRUG DISCOVERY MARKET, BY PRODUCT AND SERVICE
6.1 OVERVIEW
6.2 SOFTWARE
6.3 SERVICES
7 GLOBAL AI IN DRUG DISCOVERY MARKET, BY MOLECULE TYPE
7.1 OVERVIEW
7.2 LARGE MOLECULE
7.3 SMALL MOLECULE
8 GLOBAL AI IN DRUG DISCOVERY MARKET, BY TECHNOLOGY
8.1 OVERVIEW
8.2 MACHINE LEARNING
8.3 DEEP LEARNING
8.4 OTHERS
9 GLOBAL AI IN DRUG DISCOVERY MARKET, BY INDICATION
9.1 OVERVIEW
9.2 IMMUNO-ONCOLOGY
9.3 NEURODEGENERATIVE DISEASES
9.4 CARDIOVASCULAR DISEASES
9.5 METABOLIC DISEASES
9.6 OTHERS
10 GLOBAL AI IN DRUG DISCOVERY MARKET, BY APPLICATION
10.1 OVERVIEW
10.2 TARGET IDENTIFICATION
10.3 CANDIDATE SCREENING
10.4 DE NOVO DRUG DESIGNING
10.5 DRUG OPTIMIZATION AND REPURPOSING
10.6 PRECLINICAL TESTING
11 GLOBAL AI IN DRUG DISCOVERY MARKET, BY REGION
11.1 OVERVIEW
11.2 NORTH AMERICA
11.2.1 US
11.2.2 CANADA
11.3 EUROPE
11.3.1 GERMANY
11.3.2 FRANCE
11.3.3 UK
11.3.4 ITALY
11.3.5 SPAIN
11.3.6 REST OF EUROPE
11.4 ASIA-PACIFIC
11.4.1 CHINA
11.4.2 JAPAN
11.4.3 INDIA
11.4.4 AUSTRALIA
11.4.5 SOUTH KOREA
11.4.6 REST OF ASIA-PACIFIC
11.5 REST OF THE WORLD
11.5.1 MIDDLE EAST
11.5.2 AFRICA
11.5.3 LATIN AMERICA
12 COMPETITIVE LANDSCAPE
12.1 OVERVIEW
12.2 COMPETITIVE BENCHMARKING
12.3 MAJOR GROWTH STRATEGY IN THE GLOBAL AI IN DRUG DISCOVERY MARKET
12.4 THE LEADING PLAYER IN TERMS OF THE NUMBER OF DEVELOPMENTS IN THE GLOBAL AI IN DRUG DISCOVERY MARKET
12.5 KEY DEVELOPMENT ANALYSIS
12.6 KEY DEVELOPMENTS & GROWTH STRATEGIES
12.6.1 SERVICE/COMPANY LAUNCH
12.6.2 MERGER/ACQUISITION
12.6.3 PARTNERSHIP/COLLABORATION/AGREEMENT
13 COMPANY PROFILES
13.1 IBM
13.1.1 COMPANY OVERVIEW
13.1.2 FINANCIAL OVERVIEW
13.1.3 SOFTWARE/SERVICES OFFERED
13.1.4 KEY DEVELOPMENTS
13.1.5 SWOT ANALYSIS
13.1.6 KEY STRATEGIES
13.2 ALPHABET INC.
13.2.1 COMPANY OVERVIEW
13.2.2 FINANCIAL OVERVIEW
13.2.3 SOFTWARE/SERVICES OFFERED
13.2.4 KEY DEVELOPMENTS
13.2.5 SWOT ANALYSIS
13.2.6 KEY STRATEGIES
13.3 ATOMWISE INC.
13.3.1 COMPANY OVERVIEW
13.3.2 FINANCIAL OVERVIEW
13.3.3 SOFTWARE/SERVICES OFFERED
13.3.4 KEY DEVELOPMENTS
13.3.5 SWOT ANALYSIS
13.3.6 KEY STRATEGIES
13.4 DEEP GENOMICS
13.4.1 COMPANY OVERVIEW
13.4.2 FINANCIAL OVERVIEW
13.4.3 SOFTWARE/SERVICES OFFERED
13.4.4 KEY DEVELOPMENTS
13.4.5 KEY STRATEGIES
13.5 CLOUD PHARMACEUTICALS, INC.
13.5.1 COMPANY OVERVIEW
13.5.2 FINANCIAL OVERVIEW
13.5.3 SOFTWARE/SERVICES OFFERED
13.5.4 KEY DEVELOPMENTS
13.5.5 KEY STRATEGIES
13.6 MICROSOFT CORPORATION
13.6.1 COMPANY OVERVIEW
13.6.2 FINANCIAL OVERVIEW
13.6.3 SERVICES OFFERED
13.6.4 KEY DEVELOPMENTS
13.6.5 SWOT ANALYSIS
13.6.6 KEY STRATEGIES
13.7 INSILICO MEDICINE
13.7.1 COMPANY OVERVIEW
13.7.2 FINANCIAL OVERVIEW
13.7.3 SERVICES OFFERED
13.7.4 KEY DEVELOPMENTS
13.7.5 KEY STRATEGIES
13.8 CYCLICA
13.8.1 COMPANY OVERVIEW
13.8.2 FINANCIAL OVERVIEW
13.8.3 SERVICES OFFERED
13.8.4 KEY DEVELOPMENTS
13.8.5 KEY STRATEGIES
13.9 BENEVOLENTAI
13.9.1 COMPANY OVERVIEW
13.9.2 FINANCIAL OVERVIEW
13.9.3 SERVICES OFFERED
13.9.4 KEY DEVELOPMENTS
13.9.5 SWOT ANALYSIS
13.9.6 KEY STRATEGIES
13.10 EXSCIENTIA
13.10.1 COMPANY OVERVIEW
13.10.2 FINANCIAL OVERVIEW
13.10.3 SOFTWARES OFFERED
13.10.4 KEY DEVELOPMENTS
13.10.5 KEY STRATEGIES
14 APPENDIX
14.1 REFERENCES
14.2 RELATED REPORTS
LIST OF TABLES
TABLE 1 LIST OF ASSUMPTIONS & LIMITATIONS
TABLE 2 GLOBAL AI IN DRUG DISCOVERY MARKET, BY PRODUCT & SERVICE, 2019–2032 (USD BILLION)
TABLE 3 GLOBAL AI IN DRUG DISCOVERY MARKET, FOR PRODUCT, BY REGION, 2019–2032 (USD BILLION)
TABLE 4 GLOBAL AI IN DRUG DISCOVERY MARKET, FOR SERVICES, BY REGION, 2019–2032 (USD BILLION)
TABLE 5 GLOBAL AI IN DRUG DISCOVERY MARKET, BY MOLECULE TYPE, 2019–2032 (USD BILLION)
TABLE 6 GLOBAL AI IN DRUG DISCOVERY MARKET, FOR LARGE MOLECULE, BY REGION, 2019–2032 (USD BILLION)
TABLE 7 GLOBAL AI IN DRUG DISCOVERY MARKET, FOR SMALL MOLECULE, BY REGION, 2019–2032 (USD BILLION)
TABLE 8 GLOBAL AI IN DRUG DISCOVERY MARKET, BY TECHNOLOGY, 2019–2032 (USD BILLION)
TABLE 9 GLOBAL AI IN DRUG DISCOVERY MARKET, FOR MACHINE LEARNING, BY REGION, 2019–2032 (USD BILLION)
TABLE 10 GLOBAL AI IN DRUG DISCOVERY MARKET, FOR DEEP LEARNING, BY REGION, 2019–2032 (USD BILLION)
TABLE 11 GLOBAL AI IN DRUG DISCOVERY MARKET, FOR OTHERS, BY REGION, 2019–2032 (USD BILLION)
TABLE 12 GLOBAL AI IN DRUG DISCOVERY MARKET, BY INDICATION, 2019–2032 (USD BILLION)
TABLE 13 GLOBAL AI IN DRUG DISCOVERY MARKET, FOR IMMUNO-ONCOLOGY, BY REGION, 2019–2032 (USD BILLION)
TABLE 14 GLOBAL AI IN DRUG DISCOVERY MARKET, FOR NEURODEGENERATIVE DISEASES, BY REGION, 2019–2032 (USD BILLION)
TABLE 15 GLOBAL AI IN DRUG DISCOVERY MARKET, FOR CARDIOVASCULAR DISEASES, BY REGION, 2019–2032 (USD BILLION)
TABLE 16 GLOBAL AI IN DRUG DISCOVERY MARKET, FOR METABOLIC DISEASES, BY REGION, 2019–2032 (USD BILLION)
TABLE 17 GLOBAL AI IN DRUG DISCOVERY MARKET, FOR OTHERS, BY REGION, 2019–2032 (USD BILLION)
TABLE 18 GLOBAL AI IN DRUG DISCOVERY MARKET, BY APPLICATION, 2019–2032 (USD BILLION)
TABLE 19 GLOBAL AI IN DRUG DISCOVERY MARKET, FOR TARGET IDENTIFICATION, BY REGION, 2019–2032 (USD BILLION)
TABLE 20 GLOBAL AI IN DRUG DISCOVERY MARKET, FOR CANDIDATE SCREENING, BY REGION, 2019–2032 (USD BILLION)
TABLE 21 GLOBAL AI IN DRUG DISCOVERY MARKET, FOR DE NOVO DRUG DESIGNING, BY REGION, 2019–2032 (USD BILLION)
TABLE 22 GLOBAL AI IN DRUG DISCOVERY MARKET, FOR DRUG OPTIMIZATION AND REPURPOSING, BY REGION, 2019–2032 (USD BILLION)
TABLE 23 GLOBAL AI IN DRUG DISCOVERY MARKET, FOR PRECLINICAL TESTING, BY REGION, 2019–2032 (USD BILLION)
TABLE 24 GLOBAL AI IN DRUG DISCOVERY MARKET, BY REGION, 2019–2032 (USD BILLION)
TABLE 25 NORTH AMERICA: AI IN DRUG DISCOVERY MARKET, BY COUNTRY, 2019–2032 (USD BILLION)
TABLE 26 NORTH AMERICA AI IN DRUG DISCOVERY MARKET, BY PRODUCT & SERVICE, 2019–2032 (USD BILLION)
TABLE 27 NORTH AMERICA AI IN DRUG DISCOVERY MARKET, BY MOLECULE TYPE, 2019–2032 (USD BILLION)
TABLE 28 NORTH AMERICA AI IN DRUG DISCOVERY MARKET, BY TECHNOLOGY, 2019–2032 (USD BILLION)
TABLE 29 NORTH AMERICA AI IN DRUG DISCOVERY MARKET, BY INDICATION, 2019–2032 (USD BILLION)
TABLE 30 NORTH AMERICA AI IN DRUG DISCOVERY MARKET, BY APPLICATION, 2019–2032 (USD BILLION)
TABLE 31 US AI IN DRUG DISCOVERY MARKET, BY PRODUCT & SERVICE, 2019–2032 (USD BILLION)
TABLE 32 US AI IN DRUG DISCOVERY MARKET, BY MOLECULE TYPE, 2019–2032 (USD BILLION)
TABLE 33 US AI IN DRUG DISCOVERY MARKET, BY TECHNOLOGY, 2019–2032 (USD BILLION)
TABLE 34 US AI IN DRUG DISCOVERY MARKET, BY INDICATION, 2019–2032 (USD BILLION)
TABLE 35 US AI IN DRUG DISCOVERY MARKET, BY APPLICATION, 2019–2032 (USD BILLION)
TABLE 36 CANADA AI IN DRUG DISCOVERY MARKET, BY PRODUCT & SERVICE, 2019–2032 (USD BILLION)
TABLE 37 CANADA AI IN DRUG DISCOVERY MARKET, BY MOLECULE TYPE, 2019–2032 (USD BILLION)
TABLE 38 CANADA AI IN DRUG DISCOVERY MARKET, BY TECHNOLOGY, 2019–2032 (USD BILLION)
TABLE 39 CANADA AI IN DRUG DISCOVERY MARKET, BY INDICATION, 2019–2032 (USD BILLION)
TABLE 40 CANADA AI IN DRUG DISCOVERY MARKET, BY APPLICATION, 2019–2032 (USD BILLION)
TABLE 41 EUROPE: AI IN DRUG DISCOVERY MARKET, BY COUNTRY, 2019–2032 (USD BILLION)
TABLE 42 EUROPE AI IN DRUG DISCOVERY MARKET, BY PRODUCT & SERVICE, 2019–2032 (USD BILLION)
TABLE 43 EUROPE AI IN DRUG DISCOVERY MARKET, BY MOLECULE TYPE, 2019–2032 (USD BILLION)
TABLE 44 EUROPE AI IN DRUG DISCOVERY MARKET, BY TECHNOLOGY, 2019–2032 (USD BILLION)
TABLE 45 EUROPE AI IN DRUG DISCOVERY MARKET, BY INDICATION, 2019–2032 (USD BILLION)
TABLE 46 EUROPE AI IN DRUG DISCOVERY MARKET, BY APPLICATION, 2019–2032 (USD BILLION)
TABLE 47 GERMANY AI IN DRUG DISCOVERY MARKET, BY PRODUCT & SERVICE, 2019–2032 (USD BILLION)
TABLE 48 GERMANY AI IN DRUG DISCOVERY MARKET, BY MOLECULE TYPE, 2019–2032 (USD BILLION)
TABLE 49 GERMANY AI IN DRUG DISCOVERY MARKET, BY TECHNOLOGY, 2019–2032 (USD BILLION)
TABLE 50 GERMANY AI IN DRUG DISCOVERY MARKET, BY INDICATION, 2019–2032 (USD BILLION)
TABLE 51 GERMANY AI IN DRUG DISCOVERY MARKET, BY APPLICATION, 2019–2032 (USD BILLION)
TABLE 52 FRANCE AI IN DRUG DISCOVERY MARKET, BY PRODUCT & SERVICE, 2019–2032 (USD BILLION)
TABLE 53 FRANCE AI IN DRUG DISCOVERY MARKET, BY MOLECULE TYPE, 2019–2032 (USD BILLION)
TABLE 54 FRANCE AI IN DRUG DISCOVERY MARKET, BY TECHNOLOGY, 2019–2032 (USD BILLION)
TABLE 55 FRANCE AI IN DRUG DISCOVERY MARKET, BY INDICATION, 2019–2032 (USD BILLION)
TABLE 56 FRANCE AI IN DRUG DISCOVERY MARKET, BY APPLICATION, 2019–2032 (USD BILLION)
TABLE 57 UK AI IN DRUG DISCOVERY MARKET, BY PRODUCT & SERVICE, 2019–2032 (USD BILLION)
TABLE 58 UK AI IN DRUG DISCOVERY MARKET, BY MOLECULE TYPE, 2019–2032 (USD BILLION)
TABLE 59 UK AI IN DRUG DISCOVERY MARKET, BY TECHNOLOGY, 2019–2032 (USD BILLION)
TABLE 60 UK AI IN DRUG DISCOVERY MARKET, BY INDICATION, 2019–2032 (USD BILLION)
TABLE 61 UK AI IN DRUG DISCOVERY MARKET, BY APPLICATION, 2019–2032 (USD BILLION)
TABLE 62 ITALY AI IN DRUG DISCOVERY MARKET, BY PRODUCT & SERVICE, 2019–2032 (USD BILLION)
TABLE 63 ITALY AI IN DRUG DISCOVERY MARKET, BY MOLECULE TYPE, 2019–2032 (USD BILLION)
TABLE 64 ITALY AI IN DRUG DISCOVERY MARKET, BY TECHNOLOGY, 2019–2032 (USD BILLION)
TABLE 65 ITALY AI IN DRUG DISCOVERY MARKET, BY INDICATION, 2019–2032 (USD BILLION)
TABLE 66 ITALY AI IN DRUG DISCOVERY MARKET, BY APPLICATION, 2019–2032 (USD BILLION)
TABLE 67 SPAIN AI IN DRUG DISCOVERY MARKET, BY PRODUCT & SERVICE, 2019–2032 (USD BILLION)
TABLE 68 SPAIN AI IN DRUG DISCOVERY MARKET, BY MOLECULE TYPE, 2019–2032 (USD BILLION)
TABLE 69 SPAIN AI IN DRUG DISCOVERY MARKET, BY TECHNOLOGY, 2019–2032 (USD BILLION)
TABLE 70 SPAIN AI IN DRUG DISCOVERY MARKET, BY INDICATION, 2019–2032 (USD BILLION)
TABLE 71 SPAIN AI IN DRUG DISCOVERY MARKET, BY APPLICATION, 2019–2032 (USD BILLION)
TABLE 72 REST OF EUROPE AI IN DRUG DISCOVERY MARKET, BY PRODUCT & SERVICE, 2019–2032 (USD BILLION)
TABLE 73 REST OF EUROPE AI IN DRUG DISCOVERY MARKET, BY MOLECULE TYPE, 2019–2032 (USD BILLION)
TABLE 74 REST OF EUROPE AI IN DRUG DISCOVERY MARKET, BY TECHNOLOGY, 2019–2032 (USD BILLION)
TABLE 75 REST OF EUROPE AI IN DRUG DISCOVERY MARKET, BY INDICATION, 2019–2032 (USD BILLION)
TABLE 76 REST OF EUROPE AI IN DRUG DISCOVERY MARKET, BY APPLICATION, 2019–2032 (USD BILLION)
TABLE 77 ASIA-PACIFIC: AI IN DRUG DISCOVERY MARKET, BY COUNTRY, 2018-2030 (USD BILLION)
TABLE 78 ASIA-PACIFIC AI IN DRUG DISCOVERY MARKET, BY PRODUCT & SERVICE, 2019–2032 (USD BILLION)
TABLE 79 ASIA-PACIFIC AI IN DRUG DISCOVERY MARKET, BY MOLECULE TYPE, 2019–2032 (USD BILLION)
TABLE 80 ASIA-PACIFIC AI IN DRUG DISCOVERY MARKET, BY TECHNOLOGY, 2019–2032 (USD BILLION)
TABLE 81 ASIA-PACIFIC AI IN DRUG DISCOVERY MARKET, BY INDICATION, 2019–2032 (USD BILLION)
TABLE 82 ASIA-PACIFIC AI IN DRUG DISCOVERY MARKET, BY APPLICATION, 2019–2032 (USD BILLION)
TABLE 83 CHINA AI IN DRUG DISCOVERY MARKET, BY PRODUCT & SERVICE, 2019–2032 (USD BILLION)
TABLE 84 CHINA AI IN DRUG DISCOVERY MARKET, BY MOLECULE TYPE, 2019–2032 (USD BILLION)
TABLE 85 CHINA AI IN DRUG DISCOVERY MARKET, BY TECHNOLOGY, 2019–2032 (USD BILLION)
TABLE 86 CHINA AI IN DRUG DISCOVERY MARKET, BY INDICATION, 2019–2032 (USD BILLION)
TABLE 87 CHINA AI IN DRUG DISCOVERY MARKET, BY APPLICATION, 2019–2032 (USD BILLION)
TABLE 88 JAPAN AI IN DRUG DISCOVERY MARKET, BY PRODUCT & SERVICE, 2019–2032 (USD BILLION)
TABLE 89 JAPAN AI IN DRUG DISCOVERY MARKET, BY MOLECULE TYPE, 2019–2032 (USD BILLION)
TABLE 90 JAPAN AI IN DRUG DISCOVERY MARKET, BY TECHNOLOGY, 2019–2032 (USD BILLION)
TABLE 91 JAPAN AI IN DRUG DISCOVERY MARKET, BY INDICATION, 2019–2032 (USD BILLION)
TABLE 92 JAPAN AI IN DRUG DISCOVERY MARKET, BY APPLICATION, 2019–2032 (USD BILLION)
TABLE 93 INDIA AI IN DRUG DISCOVERY MARKET, BY PRODUCT & SERVICE, 2019–2032 (USD BILLION)
TABLE 94 INDIA AI IN DRUG DISCOVERY MARKET, BY MOLECULE TYPE, 2019–2032 (USD BILLION)
TABLE 95 INDIA AI IN DRUG DISCOVERY MARKET, BY TECHNOLOGY, 2019–2032 (USD BILLION)
TABLE 96 INDIA AI IN DRUG DISCOVERY MARKET, BY INDICATION, 2019–2032 (USD BILLION)
TABLE 97 INDIA AI IN DRUG DISCOVERY MARKET, BY APPLICATION, 2019–2032 (USD BILLION)
TABLE 98 AUSTRALIA AI IN DRUG DISCOVERY MARKET, BY PRODUCT & SERVICE, 2019–2032 (USD BILLION)
TABLE 99 AUSTRALIA AI IN DRUG DISCOVERY MARKET, BY MOLECULE TYPE, 2019–2032 (USD BILLION)
TABLE 100 AUSTRALIA AI IN DRUG DISCOVERY MARKET, BY TECHNOLOGY, 2019–2032 (USD BILLION)
TABLE 101 AUSTRALIA AI IN DRUG DISCOVERY MARKET, BY INDICATION, 2019–2032 (USD BILLION)
TABLE 102 AUSTRALIA AI IN DRUG DISCOVERY MARKET, BY APPLICATION, 2019–2032 (USD BILLION)
TABLE 103 SOUTH KOREA AI IN DRUG DISCOVERY MARKET, BY PRODUCT & SERVICE, 2019–2032 (USD BILLION)
TABLE 104 SOUTH KOREA AI IN DRUG DISCOVERY MARKET, BY MOLECULE TYPE, 2019–2032 (USD BILLION)
TABLE 105 SOUTH KOREA AI IN DRUG DISCOVERY MARKET, BY TECHNOLOGY, 2019–2032 (USD BILLION)
TABLE 106 SOUTH KOREA AI IN DRUG DISCOVERY MARKET, BY INDICATION, 2019–2032 (USD BILLION)
TABLE 107 SOUTH KOREA AI IN DRUG DISCOVERY MARKET, BY APPLICATION, 2019–2032 (USD BILLION)
TABLE 108 REST OF ASIA-PACIFIC AI IN DRUG DISCOVERY MARKET, BY PRODUCT & SERVICE, 2019–2032 (USD BILLION)
TABLE 109 REST OF ASIA-PACIFIC AI IN DRUG DISCOVERY MARKET, BY MOLECULE TYPE, 2019–2032 (USD BILLION)
TABLE 110 REST OF ASIA-PACIFIC AI IN DRUG DISCOVERY MARKET, BY TECHNOLOGY, 2019–2032 (USD BILLION)
TABLE 111 REST OF ASIA-PACIFIC AI IN DRUG DISCOVERY MARKET, BY INDICATION, 2019–2032 (USD BILLION)
TABLE 112 REST OF ASIA-PACIFIC AI IN DRUG DISCOVERY MARKET, BY APPLICATION, 2019–2032 (USD BILLION)
TABLE 113 REST OF THE WORLD: AI IN DRUG DISCOVERY MARKET, BY REGION, 2018-2030 (USD BILLION)
TABLE 114 REST OF THE WORLD AI IN DRUG DISCOVERY MARKET, BY PRODUCT & SERVICE, 2019–2032 (USD BILLION)
TABLE 115 REST OF THE WORLD AI IN DRUG DISCOVERY MARKET, BY MOLECULE TYPE, 2019–2032 (USD BILLION)
TABLE 116 REST OF THE WORLD AI IN DRUG DISCOVERY MARKET, BY TECHNOLOGY, 2019–2032 (USD BILLION)
TABLE 117 REST OF THE WORLD AI IN DRUG DISCOVERY MARKET, BY INDICATION, 2019–2032 (USD BILLION)
TABLE 118 REST OF THE WORLD AI IN DRUG DISCOVERY MARKET, BY APPLICATION, 2019–2032 (USD BILLION)
TABLE 119 MIDDLE EAST AI IN DRUG DISCOVERY MARKET, BY PRODUCT & SERVICE, 2019–2032 (USD BILLION)
TABLE 120 MIDDLE EAST AI IN DRUG DISCOVERY MARKET, BY MOLECULE TYPE, 2019–2032 (USD BILLION)
TABLE 121 MIDDLE EAST AI IN DRUG DISCOVERY MARKET, BY TECHNOLOGY, 2019–2032 (USD BILLION)
TABLE 122 MIDDLE EAST AI IN DRUG DISCOVERY MARKET, BY INDICATION, 2019–2032 (USD BILLION)
TABLE 123 MIDDLE EAST AI IN DRUG DISCOVERY MARKET, BY APPLICATION, 2019–2032 (USD BILLION)
TABLE 124 AFRICA AI IN DRUG DISCOVERY MARKET, BY PRODUCT & SERVICE, 2019–2032 (USD BILLION)
TABLE 125 AFRICA AI IN DRUG DISCOVERY MARKET, BY MOLECULE TYPE, 2019–2032 (USD BILLION)
TABLE 126 AFRICA AI IN DRUG DISCOVERY MARKET, BY TECHNOLOGY, 2019–2032 (USD BILLION)
TABLE 127 AFRICA AI IN DRUG DISCOVERY MARKET, BY INDICATION, 2019–2032 (USD BILLION)
TABLE 128 AFRICA AI IN DRUG DISCOVERY MARKET, BY APPLICATION, 2019–2032 (USD BILLION)
TABLE 129 LATIN AMERICA AI IN DRUG DISCOVERY MARKET, BY PRODUCT & SERVICE, 2019–2032 (USD BILLION)
TABLE 130 LATIN AMERICA AI IN DRUG DISCOVERY MARKET, BY MOLECULE TYPE, 2019–2032 (USD BILLION)
TABLE 131 LATIN AMERICA AI IN DRUG DISCOVERY MARKET, BY TECHNOLOGY, 2019–2032 (USD BILLION)
TABLE 132 LATIN AMERICA AI IN DRUG DISCOVERY MARKET, BY INDICATION, 2019–2032 (USD BILLION)
TABLE 133 LATIN AMERICA AI IN DRUG DISCOVERY MARKET, BY APPLICATION, 2019–2032 (USD BILLION)
TABLE 134 MAJOR PLAYERS IN THE GLOBAL AI IN DRUG DISCOVERY MARKET
TABLE 135 MOST ACTIVE PLAYER IN THE GLOBAL AI IN DRUG DISCOVERY MARKET
TABLE 136 SERVICE/COMPANY LAUNCH
TABLE 137 MERGER/ACQUISITION
TABLE 138 PARTNERSHIP/COLLABORATION/AGREEMENT
TABLE 139 IBM: SOFTWARE/SERVICES OFFERED
TABLE 140 IBM: KEY DEVELOPMENTS
TABLE 141 ALPHABET INC.: SOFTWARE/SERVICES OFFERED
TABLE 142 ALPHABET INC.: KEY DEVELOPMENTS
TABLE 143 ATOMWISE INC.: SOFTWARE/SERVICES OFFERED
TABLE 144 ATOMWISE INC.: KEY DEVELOPMENTS
TABLE 145 DEEP GENOMICS: SOFTWARE/SERVICES OFFERED
TABLE 146 CLOUD PHARMACEUTICALS, INC.: SOFTWARE/SERVICES OFFERED
TABLE 147 CLOUD PHARMACEUTICALS, INC.: KEY DEVELOPMENTS
TABLE 148 MICROSOFT CORPORATION: SERVICES OFFERED
TABLE 149 INSILICO MEDICINE: SERVICES OFFERED
TABLE 150 CYCLICA: SERVICES OFFERED
TABLE 151 BENEVOLENTAI: SERVICES OFFERED
TABLE 152 EXSCIENTIA: SOFTWARES OFFERED
LIST OF FIGURES
FIGURE 1 GLOBAL AI IN DRUG DISCOVERY MARKET STRUCTURE
FIGURE 2 BOTTOM-UP AND TOP-DOWN APPROACHES
FIGURE 3 MARKET DYNAMICS: ANALYSIS OF THE AI IN DRUG DISCOVERY
FIGURE 4 DRIVER IMPACT ANALYSIS
FIGURE 5 RESTRAINT IMPACT ANALYSIS
FIGURE 6 VALUE CHAIN ANALYSIS: GLOBAL AI IN DRUG DISCOVERY
FIGURE 7 PORTER'S FIVE FORCES ANALYSIS: GLOBAL AI IN DRUG DISCOVERY
FIGURE 8 GLOBAL AI IN DRUG DISCOVERY MARKET, BY PRODUCT & SERVICE, 2022 & 2032 (USD BILLION)
FIGURE 9 GLOBAL AI IN DRUG DISCOVERY MARKET, BY MOLECULE TYPE, 2022 & 2032 (USD BILLION)
FIGURE 10 GLOBAL AI IN DRUG DISCOVERY MARKET, BY TECHNOLOGY, 2022 & 2032 (USD BILLION)
FIGURE 11 GLOBAL AI IN DRUG DISCOVERY MARKET, BY INDICATION, 2022 & 2032 (USD BILLION)
FIGURE 12 GLOBAL AI IN DRUG DISCOVERY MARKET, BY APPLICATION, 2022 & 2032 (USD BILLION)
FIGURE 13 GLOBAL AI IN DRUG DISCOVERY MARKET: BY REGION, 2022 & 2032 (USD BILLION)
FIGURE 14 GLOBAL AI IN DRUG DISCOVERY MARKET SHARE (%), BY REGION, 2022
FIGURE 15 NORTH AMERICA: AI IN DRUG DISCOVERY MARKET SHARE (%), BY COUNTRY, 2022
FIGURE 16 EUROPE: AI IN DRUG DISCOVERY MARKET SHARE (%), BY COUNTRY, 2022
FIGURE 17 ASIA-PACIFIC: AI IN DRUG DISCOVERY MARKET SHARE (%), BY COUNTRY, 2022
FIGURE 18 REST OF THE WORLD: AI IN DRUG DISCOVERY MARKET SHARE (%), BY REGION, 2022
FIGURE 19 BENCHMARKING OF MAJOR COMPETITORS
FIGURE 20 MAJOR STRATEGY ADOPTED BY KEY PLAYERS IN THE GLOBAL AI IN DRUG DISCOVERY MARKET
FIGURE 21 GLOBAL AI IN DRUG DISCOVERY MARKET: COMPETITIVE LANDSCAPE
FIGURE 22 IBM: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 23 IBM: SWOT ANALYSIS
FIGURE 24 ALPHABET INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 25 ALPHABET INC.: SWOT ANALYSIS
FIGURE 26 ATOMWISE INC.: SWOT ANALYSIS
FIGURE 27 MICROSOFT CORPORATION: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 28 MICROSOFT CORPORATION: SWOT ANALYSIS
FIGURE 29 BENEVOLENTAI: SWOT ANALYSIS
FIGURE 30 EXSCIENTIA: FINANCIAL OVERVIEW SNAPSHOT
